Clinical Trial Update: Zanubrutinib-based Induction and Maintenance Therapy in Young and Fit Patients With Untreated Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

A phase 2 clinical trial investigating zanubrutinib-based induction and maintenance therapy in young, fit patients with untreated mantle cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: UNKNOWN